Subscribe To
NBTX / Why is Nanobiotix (NBTX) Stock Up 107% Today?
NBTX News
By Seeking Alpha
September 27, 2023
Nanobiotix S.A. (NBTX) Q2 2023 Earnings Call Transcript
Nanobiotix S.A. (NASDAQ:NBTX ) Q2 2023 Earnings Conference Call September 27, 2023 8:00 AM ET Company Participants Craig West - SVP, IR Laurent Levy - more_horizontal
By Seeking Alpha
August 24, 2023
Nanobiotix: At A Crucial Juncture For Data
Nanobiotix is an oncology-focused biotech aiming for its first drug approval, with a tripled value since the beginning of 2023. Their flagship molecul more_horizontal
By Proactive Investors
May 5, 2023
Nanobiotix stock skyrockets on final negotiations with ‘major' drug maker for its cancer treatment
Nanobiotix SA (EPA:NANO) shares soared 250% to $7.11, on volume of more than 29 million shares, Friday after the France-based clinical biotechnology c more_horizontal
By Market Watch
May 5, 2023
Nanobiotix stock more than triples, after biotech enters final negotiations with ‘major' drug maker on development of cancer treatment
The U.S.-listed shares of Nanobiotix S.A. NBTX blasted 221.7% higher on massive volume Friday, to pace all gainers trading on major U.S. exchanges, af more_horizontal
By InvestorPlace
May 5, 2023
Why is Nanobiotix (NBTX) Stock Up 107% Today?
Nanobiotix (NASDAQ: NBTX ) stock is taking off on Friday after the company revealed details about ongoing contract negotiations for NBTXR3. NBTXR3 is more_horizontal
By Seeking Alpha
March 31, 2022
Nanobiotix S.A (NBTX) CEO Laurent Levy on Q4 2021 Results - Earnings Call Transcript
Nanobiotix S.A (NBTX) CEO Laurent Levy on Q4 2021 Results - Earnings Call Transcript more_horizontal